Incorporates an active component that will significantly shorten the treatment duration of MPE compared to current catheter devices.
A user-friendly design to promote patient independence, comfort and quality of life.
Reduces the costs associated with long-term home drainage and acute readmissions to hospital.
Posted in News by Nate Reynolds
20th November, 2023
November is proving to be a fruitful month this year as SymPhysis Medical have been nominated for not one but three awards. Firstly, the Excellence in Innovation Award is a part...
Read morePosted in News by Nate Reynolds
15th November, 2023
Last month, a number of client companies of ATU iHubs came together to host an onsite comedy show in aid of the National Breast Cancer Research Institute as part of...
Read more
Posted in News by Nate Reynolds
19th July, 2023
SymPhysis Medical were thrilled to win the “Innovation of the Year” award at the Life Sciences Industry Awards which took place in Dublin on 7 July, 2023. Tim Jones and...
Read more
Posted in News by Nate Reynolds
14th June, 2023
In May 2023, SymPhysis Medical was delighted to be nominated for Innovation of the Year Award in the inaugural year of The Life Science Industry Awards for its first drainage...
Read more
Affects ~90% of patients with mesothelioma.
Affects ~ 35% of patients with lung cancer.
Affects ~ 16% of patients with breast cancer.
Affects ~ 11% of patients with lymphoma.
